Atossa Therapeutics (ATOS) Other Non-Current Assets (2011 - 2026)
Atossa Therapeutics (ATOS) reported Other Non-Current Assets of $1.27 million for Q2 2026, down 36.4% from $2 million a year earlier and down 0.3% from the prior quarter.
Atossa Therapeutics (ATOS) Other Non-Current Assets (2011 - 2026) Analysis & Trends
At the end of FY2025, Atossa Therapeutics posted Other Non-Current Assets of $1.99 million, up 0.2% from FY2024.
- Other Non-Current Assets has a five-year compound annual growth rate of 159.2% (FY2020 to FY2025).
- By year, Other Non-Current Assets came in at $1.99 million in FY2024 (-14.5%), $2.32 million in FY2023 (+265.8%), $635,000 in FY2022 and $22,000 in FY2021 (+29.4%).
- The Q2 2026 figure ranks as the lowest quarterly Other Non-Current Assets since Q2 2023.
- Year over year, Other Non-Current Assets gained in two of the last eight quarters, with an average decline of 14.8%.
- The high point for year-over-year Other Non-Current Assets in five years was Q2 2024 (growth of 278.5%); the low point was Q2 2026 (a decline of 36.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.28 million (Q1 2026), $1.99 million (Q4 2025) and $2.33 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 14.27 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 10.73 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 19.60 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.93 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 12.98 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 4.75 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 9.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Atossa Therapeutics | 19.46 Mn | 19.46 Mn | - | 1.27 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.27 Mn |
| Mar 31, 2026 | 1.28 Mn |
| Dec 31, 2025 | 1.99 Mn |
| Sep 30, 2025 | 2.33 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Dec 31, 2024 | 1.99 Mn |
| Sep 30, 2024 | 2.37 Mn |
| Jun 30, 2024 | 2.43 Mn |
| Mar 31, 2024 | 2.32 Mn |
| Dec 31, 2023 | 2.32 Mn |
| Sep 30, 2023 | 2.34 Mn |
| Jun 30, 2023 | 642,000.00 |
| Mar 31, 2023 | 631,000.00 |
| Dec 31, 2022 | 635,000.00 |
| Sep 30, 2022 | 629,000.00 |
| Jun 30, 2022 | 627,000.00 |
| Mar 31, 2022 | 630,000.00 |
| Dec 31, 2021 | 22,000.00 |
| Sep 30, 2021 | 14,218.00 |
Atossa Therapeutics Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ATOS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "ATOS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ATOS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();